Quantum-Si to Showcase Major Advancements in Proteus™ Platform and Share Insights on Its Leading Technology Pipeline at Investor & Analyst Day
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 19 2025
0mins
Should l Buy QSI?
Source: Newsfilter
Investor & Analyst Day Announcement: Quantum-Si Incorporated is hosting an Investor & Analyst Day in New York City to present updates on its Proteus™ platform development, including a long-term technology roadmap and advancements in post-translational modification methods.
Proteus Platform Progress: The company has successfully completed over 50 sequencing runs on its prototype Proteus unit, achieving performance that meets or exceeds its current Platinum® Pro system, with plans for further optimization.
Amino Acid Detection: Quantum-Si has accelerated its path to detecting all 20 amino acids through collaborations and advanced computational tools, enhancing its capabilities in proteomics.
Forward-Looking Statements: The press release includes forward-looking statements regarding the company's future performance and product development, highlighting potential risks and uncertainties that could affect actual results.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy QSI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on QSI
Wall Street analysts forecast QSI stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.926
Low
1.50
Averages
2.67
High
4.00
Current: 0.926
Low
1.50
Averages
2.67
High
4.00
About QSI
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Quantum-Si Projects 2026 as Transition Year with Focus on Proteus Launch
- Revenue Outlook: Quantum-Si anticipates total revenue of approximately $1 million for 2026, primarily driven by consumable utilization, while new capital equipment sales are expected to remain limited, a strategy aimed at laying the groundwork for a strong commercial ramp of Proteus in 2027.
- Proteus Pricing Strategy: The list price for Proteus is set at $425,000, designed to balance its premium value with market accessibility, which is expected to attract a larger number of potential customers and drive future sales growth.
- Customer Expansion Success: The company successfully secured 17 new customers through its instrument placement program, viewed as a key market development tool to build momentum for the Proteus launch, indicating strong market demand potential.
- Financial Performance: Revenue for Q4 2025 was $451,000 with a gross margin of 27%, impacted by a higher proportion of consumable revenue and certain inventory adjustments, yet the overall financial position reflects the company's resilience during the transition year.
See More
Quantum-Si (QSI) Q4 2025 Earnings Call Transcript
See More
Quantum-Si Q4 Earnings Miss Estimates, Stock Drops
- Disappointing Earnings: Quantum-Si reported a quarterly loss of $0.08 per share, beating the Street's estimate of a $0.12 loss, but its revenue of $451,000 fell significantly short of the $762,000 forecast, indicating challenges in revenue growth.
- Pricing Strategy: The company set a list price of $425,000 for its Proteus system, which, while reflecting technological advancements, may limit market acceptance due to its high cost, potentially impacting future sales performance.
- Technological Progress and Strategic Goals: CEO Jeff Hawkins highlighted significant progress in 2025 with multiple new kit launches and demonstrated sequencing capabilities on the Proteus prototype that surpassed existing technology, showcasing the company's ongoing commitment to innovation.
- Pessimistic Outlook: Quantum-Si expects fiscal 2026 revenue of $1 million, drastically lower than the $7.15 million estimate, reflecting substantial challenges in achieving revenue growth targets, which could negatively affect investor confidence.
See More
Quantum-Si Releases Financial Guidance for FY 2026
- Earnings Report: Quantum-Si reported a Q4 GAAP EPS of -$0.08, beating expectations by $0.04, yet revenue of $0.5 million, down 58.3% year-over-year, missed estimates, indicating significant market challenges for the company.
- Annual Financial Guidance: For FY 2026, the company projects revenue of approximately $1.0 million, and while this forecast is low, the adjusted total operating expenses are expected to be $98.0 million or less, reflecting efforts to control costs amid declining revenues.
- Cash Usage Outlook: Quantum-Si anticipates cash usage of no more than $93.0 million in FY 2026, a strategy aimed at ensuring financial stability in the face of revenue declines, thereby alleviating funding pressures.
- Market Reaction: Despite exceeding EPS expectations, the substantial revenue drop has shaken market confidence in the company's future prospects, potentially impacting stock performance.
See More
Quantum-Si to Announce Q4 Earnings on March 2
- Earnings Announcement Date: Quantum-Si is set to release its Q4 earnings on March 2 after market close, with stakeholders keenly awaiting the latest financial performance to assess the company's future growth potential.
- Declining EPS Expectations: Analysts forecast a consensus EPS of -$0.13, indicating challenges in profitability that could undermine investor confidence and affect stock performance.
- Revenue Forecast Drop: The anticipated revenue for Q4 is $0.76 million, representing a 36.7% year-over-year decline, highlighting pressures in the market and a lack of growth in the company's operations.
- Market Reaction Anticipation: Given the negative financial outlook, investors may adopt a cautious stance towards Quantum-Si's stock performance, potentially impacting its short-term market behavior and long-term investment appeal.
See More
Ark Invest Unveils 2026 Big Ideas, Forecasts 1.9% GDP Growth Boost
- Technological Acceleration: Ark Invest's report highlights that capital investment in disruptive innovation platforms could contribute 1.9 percentage points to annualized real GDP growth during this decade, emphasizing the potential of technologies like robotaxis and next-gen data centers.
- Strong ETF Performance: In 2025, Ark's Autonomous Technology & Robotics ETF and Space & Defense Innovation ETF achieved returns of 49.8% and 49.2%, respectively, showcasing the firm's ability to generate returns in emerging technology sectors.
- Bitcoin Holdings Surge: The report indicates that U.S. ETFs and public companies now hold 12% of total Bitcoin supply, with Bitcoin ETF balances up 19.7% and public company Bitcoin holdings up 73% in 2025, reflecting strong market demand for digital assets.
- Diverse Investment Opportunities: Ark Invest identifies several publicly traded companies, including Coinbase, Illumina, and Waymo, as key investment opportunities for the 2026 themes, indicating the firm's forward-looking approach to diversified investment strategies.
See More
Quantum-Si Projects 2026 as Transition Year with Focus on Proteus Launch
- Revenue Outlook: Quantum-Si anticipates total revenue of approximately $1 million for 2026, primarily driven by consumable utilization, while new capital equipment sales are expected to remain limited, a strategy aimed at laying the groundwork for a strong commercial ramp of Proteus in 2027.
- Proteus Pricing Strategy: The list price for Proteus is set at $425,000, designed to balance its premium value with market accessibility, which is expected to attract a larger number of potential customers and drive future sales growth.
- Customer Expansion Success: The company successfully secured 17 new customers through its instrument placement program, viewed as a key market development tool to build momentum for the Proteus launch, indicating strong market demand potential.
- Financial Performance: Revenue for Q4 2025 was $451,000 with a gross margin of 27%, impacted by a higher proportion of consumable revenue and certain inventory adjustments, yet the overall financial position reflects the company's resilience during the transition year.
See More
Quantum-Si (QSI) Q4 2025 Earnings Call Transcript
See More
Quantum-Si Q4 Earnings Miss Estimates, Stock Drops
- Disappointing Earnings: Quantum-Si reported a quarterly loss of $0.08 per share, beating the Street's estimate of a $0.12 loss, but its revenue of $451,000 fell significantly short of the $762,000 forecast, indicating challenges in revenue growth.
- Pricing Strategy: The company set a list price of $425,000 for its Proteus system, which, while reflecting technological advancements, may limit market acceptance due to its high cost, potentially impacting future sales performance.
- Technological Progress and Strategic Goals: CEO Jeff Hawkins highlighted significant progress in 2025 with multiple new kit launches and demonstrated sequencing capabilities on the Proteus prototype that surpassed existing technology, showcasing the company's ongoing commitment to innovation.
- Pessimistic Outlook: Quantum-Si expects fiscal 2026 revenue of $1 million, drastically lower than the $7.15 million estimate, reflecting substantial challenges in achieving revenue growth targets, which could negatively affect investor confidence.
See More
Quantum-Si Releases Financial Guidance for FY 2026
- Earnings Report: Quantum-Si reported a Q4 GAAP EPS of -$0.08, beating expectations by $0.04, yet revenue of $0.5 million, down 58.3% year-over-year, missed estimates, indicating significant market challenges for the company.
- Annual Financial Guidance: For FY 2026, the company projects revenue of approximately $1.0 million, and while this forecast is low, the adjusted total operating expenses are expected to be $98.0 million or less, reflecting efforts to control costs amid declining revenues.
- Cash Usage Outlook: Quantum-Si anticipates cash usage of no more than $93.0 million in FY 2026, a strategy aimed at ensuring financial stability in the face of revenue declines, thereby alleviating funding pressures.
- Market Reaction: Despite exceeding EPS expectations, the substantial revenue drop has shaken market confidence in the company's future prospects, potentially impacting stock performance.
See More
Quantum-Si to Announce Q4 Earnings on March 2
- Earnings Announcement Date: Quantum-Si is set to release its Q4 earnings on March 2 after market close, with stakeholders keenly awaiting the latest financial performance to assess the company's future growth potential.
- Declining EPS Expectations: Analysts forecast a consensus EPS of -$0.13, indicating challenges in profitability that could undermine investor confidence and affect stock performance.
- Revenue Forecast Drop: The anticipated revenue for Q4 is $0.76 million, representing a 36.7% year-over-year decline, highlighting pressures in the market and a lack of growth in the company's operations.
- Market Reaction Anticipation: Given the negative financial outlook, investors may adopt a cautious stance towards Quantum-Si's stock performance, potentially impacting its short-term market behavior and long-term investment appeal.
See More
Ark Invest Unveils 2026 Big Ideas, Forecasts 1.9% GDP Growth Boost
- Technological Acceleration: Ark Invest's report highlights that capital investment in disruptive innovation platforms could contribute 1.9 percentage points to annualized real GDP growth during this decade, emphasizing the potential of technologies like robotaxis and next-gen data centers.
- Strong ETF Performance: In 2025, Ark's Autonomous Technology & Robotics ETF and Space & Defense Innovation ETF achieved returns of 49.8% and 49.2%, respectively, showcasing the firm's ability to generate returns in emerging technology sectors.
- Bitcoin Holdings Surge: The report indicates that U.S. ETFs and public companies now hold 12% of total Bitcoin supply, with Bitcoin ETF balances up 19.7% and public company Bitcoin holdings up 73% in 2025, reflecting strong market demand for digital assets.
- Diverse Investment Opportunities: Ark Invest identifies several publicly traded companies, including Coinbase, Illumina, and Waymo, as key investment opportunities for the 2026 themes, indicating the firm's forward-looking approach to diversified investment strategies.
See More
